Vimian Group AB (publ)
General ticker "VIMGF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $1.9B (TTM average)
Vimian Group AB (publ) does not follow the US Stock Market performance with the rate: -33.3%.
Estimated limits based on current volatility of 0.0%: low 3.01$, high 3.01$
Short-term VIMGF quotes
Long-term VIMGF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €281.31MM | €331.73MM | €374.80MM |
| Operating Expenses | €241.95MM | €290.46MM | €325.60MM |
| Operating Income | €39.36MM | €41.27MM | €49.20MM |
| Non-Operating Income | €-38.44MM | €-21.82MM | €-20.40MM |
| Interest Expense | €11.05MM | €19.25MM | €25.40MM |
| R&D Expense | €8.36MM | €5.67MM | €0.00MM |
| Income(Loss) | €0.92MM | €19.45MM | €28.80MM |
| Taxes | €8.12MM | €8.96MM | €9.50MM |
| Profit(Loss)* | €-53.76MM | €9.84MM | €18.50MM |
| Stockholders Equity | €481.81MM | €526.37MM | €699.90MM |
| Inventory | €0.00MM | €60.29MM | €78.40MM |
| Assets | €923.56MM | €973.68MM | €1,109.80MM |
| Operating Cash Flow | €25.31MM | €-28.58MM | €58.10MM |
| Capital expenditure | €10.31MM | €14.90MM | €14.20MM |
| Investing Cash Flow | €-188.53MM | €-77.68MM | €-76.00MM |
| Financing Cash Flow | €150.23MM | €100.55MM | €44.80MM |
| Earnings Per Share** | €-0.13 | €0.02 | €0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.